The global market for Drugs for Xerostomia was valued at US$ 762 million in the year 2024 and is projected to reach a revised size of US$ 965 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Drugs for Xerostomia Market

Drugs for Xerostomia include prescription and over-the-counter mouthwashes, artificial saliva or humectants to moisturize the mouth, mouthwashes specially for dry mouth, especially those containing xylitol

Xerostomia, commonly referred to as "xerostomia syndrome," is the result of reduced or absent saliva flow, resulting in dry mucous membranes. Increase in radiation therapy and chemotherapy may lead to increased incidence of xerostomia, which is expected to primarily drive the xerostomia treatment market. Other factors driving the market growth include growing geriatric population base; rising prevalence of diseases such as HIV, diabetes, and Alzheimer"s disease.

Furthermore, the geriatric population is expected to have a significant impact on the studied market. For example, according to the 2022 World Population Prospects, the global population aged 65 and over will be 771 million in 2022, and it is expected to reach 994 million by 2030 and 1.6 billion by 2050. Older adults often experience dry mouth, which is often associated with reduced salivary gland activity. Medication use, chronic disease, and radiation therapy to the head and neck area have all been cited as causes of xerostomia in older adults.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drugs for Xerostomia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Xerostomia.

The Drugs for Xerostomia market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Xerostomia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for Xerostomia manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drugs for Xerostomia Market Report

Report Metric	Details
Report Name	Drugs for Xerostomia Market
Accounted market size in year	US$ 762 million
Forecasted market size in 2031	US$ 965 million
CAGR	3.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Spray Oral Liquid Buccal Tablet Mouth Wash
Segment by Application	Supermarket Hospital Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Concordia, AMICI, Aurobindo Pharma Ltd, Impax Labs, Lannett Co Inc, Padagis Us, Amneal Pharmaceuticals Pvt. Ltd., Bausch Health Companies Inc., GSK, Jazz Pharmaceuticals plc, Mission Pharmacal Company, OraCoat, Cumberland Pharmaceuticals, Inc., Fleet, C.B., Company, Parnell Pharmaceuticals, Inc, Clinigen, Sun Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs for Xerostomia manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs for Xerostomia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Drugs for Xerostomia Market growing?

Ans: The Drugs for Xerostomia Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Drugs for Xerostomia Market size in 2031?

Ans: The Drugs for Xerostomia Market size in 2031 will be US$ 965 million.

Who are the main players in the Drugs for Xerostomia Market report?

Ans: The main players in the Drugs for Xerostomia Market are Concordia, AMICI, Aurobindo Pharma Ltd, Impax Labs, Lannett Co Inc, Padagis Us, Amneal Pharmaceuticals Pvt. Ltd., Bausch Health Companies Inc., GSK, Jazz Pharmaceuticals plc, Mission Pharmacal Company, OraCoat, Cumberland Pharmaceuticals, Inc., Fleet, C.B., Company, Parnell Pharmaceuticals, Inc, Clinigen, Sun Pharm

What are the Application segmentation covered in the Drugs for Xerostomia Market report?

Ans: The Applications covered in the Drugs for Xerostomia Market report are Supermarket, Hospital, Other

What are the Type segmentation covered in the Drugs for Xerostomia Market report?

Ans: The Types covered in the Drugs for Xerostomia Market report are Spray, Oral Liquid, Buccal Tablet, Mouth Wash

1 Drugs for Xerostomia Market Overview

1.1 Product Definition

1.2 Drugs for Xerostomia by Type

1.2.1 Global Drugs for Xerostomia Market Value Comparison by Type (2024 VS 2031)

1.2.2 Spray

1.2.3 Oral Liquid

1.2.4 Buccal Tablet

1.2.5 Mouth Wash

1.3 Drugs for Xerostomia by Application

1.3.1 Global Drugs for Xerostomia Market Value by Application (2024 VS 2031)

1.3.2 Supermarket

1.3.3 Hospital

1.3.4 Other

1.4 Global Drugs for Xerostomia Market Size Estimates and Forecasts

1.4.1 Global Drugs for Xerostomia Revenue 2020-2031

1.4.2 Global Drugs for Xerostomia Sales 2020-2031

1.4.3 Global Drugs for Xerostomia Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Drugs for Xerostomia Market Competition by Manufacturers

2.1 Global Drugs for Xerostomia Sales Market Share by Manufacturers (2020-2025)

2.2 Global Drugs for Xerostomia Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Drugs for Xerostomia Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Drugs for Xerostomia, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Drugs for Xerostomia, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Drugs for Xerostomia, Product Type & Application

2.7 Global Key Manufacturers of Drugs for Xerostomia, Date of Enter into This Industry

2.8 Global Drugs for Xerostomia Market Competitive Situation and Trends

2.8.1 Global Drugs for Xerostomia Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Drugs for Xerostomia Players Market Share by Revenue

2.8.3 Global Drugs for Xerostomia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Drugs for Xerostomia Market Scenario by Region

3.1 Global Drugs for Xerostomia Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Drugs for Xerostomia Sales by Region: 2020-2031

3.2.1 Global Drugs for Xerostomia Sales by Region: 2020-2025

3.2.2 Global Drugs for Xerostomia Sales by Region: 2026-2031

3.3 Global Drugs for Xerostomia Revenue by Region: 2020-2031

3.3.1 Global Drugs for Xerostomia Revenue by Region: 2020-2025

3.3.2 Global Drugs for Xerostomia Revenue by Region: 2026-2031

3.4 North America Drugs for Xerostomia Market Facts & Figures by Country

3.4.1 North America Drugs for Xerostomia Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Drugs for Xerostomia Sales by Country (2020-2031)

3.4.3 North America Drugs for Xerostomia Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Drugs for Xerostomia Market Facts & Figures by Country

3.5.1 Europe Drugs for Xerostomia Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Drugs for Xerostomia Sales by Country (2020-2031)

3.5.3 Europe Drugs for Xerostomia Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Drugs for Xerostomia Market Facts & Figures by Region

3.6.1 Asia Pacific Drugs for Xerostomia Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Drugs for Xerostomia Sales by Region (2020-2031)

3.6.3 Asia Pacific Drugs for Xerostomia Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Drugs for Xerostomia Market Facts & Figures by Country

3.7.1 Latin America Drugs for Xerostomia Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Drugs for Xerostomia Sales by Country (2020-2031)

3.7.3 Latin America Drugs for Xerostomia Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Drugs for Xerostomia Market Facts & Figures by Country

3.8.1 Middle East and Africa Drugs for Xerostomia Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Drugs for Xerostomia Sales by Country (2020-2031)

3.8.3 Middle East and Africa Drugs for Xerostomia Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Drugs for Xerostomia Sales by Type (2020-2031)

4.1.1 Global Drugs for Xerostomia Sales by Type (2020-2025)

4.1.2 Global Drugs for Xerostomia Sales by Type (2026-2031)

4.1.3 Global Drugs for Xerostomia Sales Market Share by Type (2020-2031)

4.2 Global Drugs for Xerostomia Revenue by Type (2020-2031)

4.2.1 Global Drugs for Xerostomia Revenue by Type (2020-2025)

4.2.2 Global Drugs for Xerostomia Revenue by Type (2026-2031)

4.2.3 Global Drugs for Xerostomia Revenue Market Share by Type (2020-2031)

4.3 Global Drugs for Xerostomia Price by Type (2020-2031)

5 Segment by Application

5.1 Global Drugs for Xerostomia Sales by Application (2020-2031)

5.1.1 Global Drugs for Xerostomia Sales by Application (2020-2025)

5.1.2 Global Drugs for Xerostomia Sales by Application (2026-2031)

5.1.3 Global Drugs for Xerostomia Sales Market Share by Application (2020-2031)

5.2 Global Drugs for Xerostomia Revenue by Application (2020-2031)

5.2.1 Global Drugs for Xerostomia Revenue by Application (2020-2025)

5.2.2 Global Drugs for Xerostomia Revenue by Application (2026-2031)

5.2.3 Global Drugs for Xerostomia Revenue Market Share by Application (2020-2031)

5.3 Global Drugs for Xerostomia Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Concordia

6.1.1 Concordia Company Information

6.1.2 Concordia Description and Business Overview

6.1.3 Concordia Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Concordia Drugs for Xerostomia Product Portfolio

6.1.5 Concordia Recent Developments/Updates

6.2 AMICI

6.2.1 AMICI Company Information

6.2.2 AMICI Description and Business Overview

6.2.3 AMICI Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.2.4 AMICI Drugs for Xerostomia Product Portfolio

6.2.5 AMICI Recent Developments/Updates

6.3 Aurobindo Pharma Ltd

6.3.1 Aurobindo Pharma Ltd Company Information

6.3.2 Aurobindo Pharma Ltd Description and Business Overview

6.3.3 Aurobindo Pharma Ltd Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Aurobindo Pharma Ltd Drugs for Xerostomia Product Portfolio

6.3.5 Aurobindo Pharma Ltd Recent Developments/Updates

6.4 Impax Labs

6.4.1 Impax Labs Company Information

6.4.2 Impax Labs Description and Business Overview

6.4.3 Impax Labs Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Impax Labs Drugs for Xerostomia Product Portfolio

6.4.5 Impax Labs Recent Developments/Updates

6.5 Lannett Co Inc

6.5.1 Lannett Co Inc Company Information

6.5.2 Lannett Co Inc Description and Business Overview

6.5.3 Lannett Co Inc Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Lannett Co Inc Drugs for Xerostomia Product Portfolio

6.5.5 Lannett Co Inc Recent Developments/Updates

6.6 Padagis Us

6.6.1 Padagis Us Company Information

6.6.2 Padagis Us Description and Business Overview

6.6.3 Padagis Us Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Padagis Us Drugs for Xerostomia Product Portfolio

6.6.5 Padagis Us Recent Developments/Updates

6.7 Amneal Pharmaceuticals Pvt. Ltd.

6.7.1 Amneal Pharmaceuticals Pvt. Ltd. Company Information

6.7.2 Amneal Pharmaceuticals Pvt. Ltd. Description and Business Overview

6.7.3 Amneal Pharmaceuticals Pvt. Ltd. Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Amneal Pharmaceuticals Pvt. Ltd. Drugs for Xerostomia Product Portfolio

6.7.5 Amneal Pharmaceuticals Pvt. Ltd. Recent Developments/Updates

6.8 Bausch Health Companies Inc.

6.8.1 Bausch Health Companies Inc. Company Information

6.8.2 Bausch Health Companies Inc. Description and Business Overview

6.8.3 Bausch Health Companies Inc. Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Bausch Health Companies Inc. Drugs for Xerostomia Product Portfolio

6.8.5 Bausch Health Companies Inc. Recent Developments/Updates

6.9 GSK

6.9.1 GSK Company Information

6.9.2 GSK Description and Business Overview

6.9.3 GSK Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.9.4 GSK Drugs for Xerostomia Product Portfolio

6.9.5 GSK Recent Developments/Updates

6.10 Jazz Pharmaceuticals plc

6.10.1 Jazz Pharmaceuticals plc Company Information

6.10.2 Jazz Pharmaceuticals plc Description and Business Overview

6.10.3 Jazz Pharmaceuticals plc Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Jazz Pharmaceuticals plc Drugs for Xerostomia Product Portfolio

6.10.5 Jazz Pharmaceuticals plc Recent Developments/Updates

6.11 Mission Pharmacal Company

6.11.1 Mission Pharmacal Company Company Information

6.11.2 Mission Pharmacal Company Description and Business Overview

6.11.3 Mission Pharmacal Company Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Mission Pharmacal Company Drugs for Xerostomia Product Portfolio

6.11.5 Mission Pharmacal Company Recent Developments/Updates

6.12 OraCoat

6.12.1 OraCoat Company Information

6.12.2 OraCoat Description and Business Overview

6.12.3 OraCoat Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.12.4 OraCoat Drugs for Xerostomia Product Portfolio

6.12.5 OraCoat Recent Developments/Updates

6.13 Cumberland Pharmaceuticals, Inc.

6.13.1 Cumberland Pharmaceuticals, Inc. Company Information

6.13.2 Cumberland Pharmaceuticals, Inc. Description and Business Overview

6.13.3 Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Product Portfolio

6.13.5 Cumberland Pharmaceuticals, Inc. Recent Developments/Updates

6.14 Fleet, C.B., Company

6.14.1 Fleet, C.B., Company Company Information

6.14.2 Fleet, C.B., Company Description and Business Overview

6.14.3 Fleet, C.B., Company Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Fleet, C.B., Company Drugs for Xerostomia Product Portfolio

6.14.5 Fleet, C.B., Company Recent Developments/Updates

6.15 Parnell Pharmaceuticals, Inc

6.15.1 Parnell Pharmaceuticals, Inc Company Information

6.15.2 Parnell Pharmaceuticals, Inc Description and Business Overview

6.15.3 Parnell Pharmaceuticals, Inc Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Parnell Pharmaceuticals, Inc Drugs for Xerostomia Product Portfolio

6.15.5 Parnell Pharmaceuticals, Inc Recent Developments/Updates

6.16 Clinigen

6.16.1 Clinigen Company Information

6.16.2 Clinigen Description and Business Overview

6.16.3 Clinigen Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Clinigen Drugs for Xerostomia Product Portfolio

6.16.5 Clinigen Recent Developments/Updates

6.17 Sun Pharm

6.17.1 Sun Pharm Company Information

6.17.2 Sun Pharm Description and Business Overview

6.17.3 Sun Pharm Drugs for Xerostomia Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Sun Pharm Drugs for Xerostomia Product Portfolio

6.17.5 Sun Pharm Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Drugs for Xerostomia Industry Chain Analysis

7.2 Drugs for Xerostomia Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Drugs for Xerostomia Production Mode & Process Analysis

7.4 Drugs for Xerostomia Sales and Marketing

7.4.1 Drugs for Xerostomia Sales Channels

7.4.2 Drugs for Xerostomia Distributors

7.5 Drugs for Xerostomia Customer Analysis

8 Drugs for Xerostomia Market Dynamics

8.1 Drugs for Xerostomia Industry Trends

8.2 Drugs for Xerostomia Market Drivers

8.3 Drugs for Xerostomia Market Challenges

8.4 Drugs for Xerostomia Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Concordia

Amici

Aurobindo Pharma Ltd.

IMPAX LABS

Lannett Co Inc

Padagis Us

Amneal Pharmaceuticals Pvt. Ltd.

Bausch Health Companies Inc.

GSK

Jazz Pharmaceuticals Plc

Mission Pharmacal Company

OraCoat

Cumberland Pharmaceuticals Inc

Parnell Pharmaceuticals, Inc.

Clinigen

Sun Pharm

Fleet, C.B., Company

List of Tables

Table 1. Global Drugs for Xerostomia Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Drugs for Xerostomia Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Drugs for Xerostomia Market Competitive Situation by Manufacturers in 2024

Table 4. Global Drugs for Xerostomia Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Drugs for Xerostomia Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Drugs for Xerostomia Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Drugs for Xerostomia Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Drugs for Xerostomia Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Drugs for Xerostomia, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Drugs for Xerostomia, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Drugs for Xerostomia, Product Type & Application

Table 12. Global Key Manufacturers of Drugs for Xerostomia, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Drugs for Xerostomia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Xerostomia as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Drugs for Xerostomia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Drugs for Xerostomia Sales by Region (2020-2025) & (K Units)

Table 18. Global Drugs for Xerostomia Sales Market Share by Region (2020-2025)

Table 19. Global Drugs for Xerostomia Sales by Region (2026-2031) & (K Units)

Table 20. Global Drugs for Xerostomia Sales Market Share by Region (2026-2031)

Table 21. Global Drugs for Xerostomia Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Drugs for Xerostomia Revenue Market Share by Region (2020-2025)

Table 23. Global Drugs for Xerostomia Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Drugs for Xerostomia Revenue Market Share by Region (2026-2031)

Table 25. North America Drugs for Xerostomia Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Drugs for Xerostomia Sales by Country (2020-2025) & (K Units)

Table 27. North America Drugs for Xerostomia Sales by Country (2026-2031) & (K Units)

Table 28. North America Drugs for Xerostomia Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Drugs for Xerostomia Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Drugs for Xerostomia Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Drugs for Xerostomia Sales by Country (2020-2025) & (K Units)

Table 32. Europe Drugs for Xerostomia Sales by Country (2026-2031) & (K Units)

Table 33. Europe Drugs for Xerostomia Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Drugs for Xerostomia Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Drugs for Xerostomia Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Drugs for Xerostomia Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Drugs for Xerostomia Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Drugs for Xerostomia Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Drugs for Xerostomia Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Drugs for Xerostomia Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Drugs for Xerostomia Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Drugs for Xerostomia Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Drugs for Xerostomia Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Drugs for Xerostomia Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Drugs for Xerostomia Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Drugs for Xerostomia Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Drugs for Xerostomia Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Drugs for Xerostomia Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Drugs for Xerostomia Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Drugs for Xerostomia Sales (K Units) by Type (2020-2025)

Table 51. Global Drugs for Xerostomia Sales (K Units) by Type (2026-2031)

Table 52. Global Drugs for Xerostomia Sales Market Share by Type (2020-2025)

Table 53. Global Drugs for Xerostomia Sales Market Share by Type (2026-2031)

Table 54. Global Drugs for Xerostomia Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Drugs for Xerostomia Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Drugs for Xerostomia Revenue Market Share by Type (2020-2025)

Table 57. Global Drugs for Xerostomia Revenue Market Share by Type (2026-2031)

Table 58. Global Drugs for Xerostomia Price (US$/Unit) by Type (2020-2025)

Table 59. Global Drugs for Xerostomia Price (US$/Unit) by Type (2026-2031)

Table 60. Global Drugs for Xerostomia Sales (K Units) by Application (2020-2025)

Table 61. Global Drugs for Xerostomia Sales (K Units) by Application (2026-2031)

Table 62. Global Drugs for Xerostomia Sales Market Share by Application (2020-2025)

Table 63. Global Drugs for Xerostomia Sales Market Share by Application (2026-2031)

Table 64. Global Drugs for Xerostomia Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Drugs for Xerostomia Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Drugs for Xerostomia Revenue Market Share by Application (2020-2025)

Table 67. Global Drugs for Xerostomia Revenue Market Share by Application (2026-2031)

Table 68. Global Drugs for Xerostomia Price (US$/Unit) by Application (2020-2025)

Table 69. Global Drugs for Xerostomia Price (US$/Unit) by Application (2026-2031)

Table 70. Concordia Company Information

Table 71. Concordia Description and Business Overview

Table 72. Concordia Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Concordia Drugs for Xerostomia Product

Table 74. Concordia Recent Developments/Updates

Table 75. AMICI Company Information

Table 76. AMICI Description and Business Overview

Table 77. AMICI Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. AMICI Drugs for Xerostomia Product

Table 79. AMICI Recent Developments/Updates

Table 80. Aurobindo Pharma Ltd Company Information

Table 81. Aurobindo Pharma Ltd Description and Business Overview

Table 82. Aurobindo Pharma Ltd Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Aurobindo Pharma Ltd Drugs for Xerostomia Product

Table 84. Aurobindo Pharma Ltd Recent Developments/Updates

Table 85. Impax Labs Company Information

Table 86. Impax Labs Description and Business Overview

Table 87. Impax Labs Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Impax Labs Drugs for Xerostomia Product

Table 89. Impax Labs Recent Developments/Updates

Table 90. Lannett Co Inc Company Information

Table 91. Lannett Co Inc Description and Business Overview

Table 92. Lannett Co Inc Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Lannett Co Inc Drugs for Xerostomia Product

Table 94. Lannett Co Inc Recent Developments/Updates

Table 95. Padagis Us Company Information

Table 96. Padagis Us Description and Business Overview

Table 97. Padagis Us Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Padagis Us Drugs for Xerostomia Product

Table 99. Padagis Us Recent Developments/Updates

Table 100. Amneal Pharmaceuticals Pvt. Ltd. Company Information

Table 101. Amneal Pharmaceuticals Pvt. Ltd. Description and Business Overview

Table 102. Amneal Pharmaceuticals Pvt. Ltd. Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Amneal Pharmaceuticals Pvt. Ltd. Drugs for Xerostomia Product

Table 104. Amneal Pharmaceuticals Pvt. Ltd. Recent Developments/Updates

Table 105. Bausch Health Companies Inc. Company Information

Table 106. Bausch Health Companies Inc. Description and Business Overview

Table 107. Bausch Health Companies Inc. Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Bausch Health Companies Inc. Drugs for Xerostomia Product

Table 109. Bausch Health Companies Inc. Recent Developments/Updates

Table 110. GSK Company Information

Table 111. GSK Description and Business Overview

Table 112. GSK Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. GSK Drugs for Xerostomia Product

Table 114. GSK Recent Developments/Updates

Table 115. Jazz Pharmaceuticals plc Company Information

Table 116. Jazz Pharmaceuticals plc Description and Business Overview

Table 117. Jazz Pharmaceuticals plc Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Jazz Pharmaceuticals plc Drugs for Xerostomia Product

Table 119. Jazz Pharmaceuticals plc Recent Developments/Updates

Table 120. Mission Pharmacal Company Company Information

Table 121. Mission Pharmacal Company Description and Business Overview

Table 122. Mission Pharmacal Company Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Mission Pharmacal Company Drugs for Xerostomia Product

Table 124. Mission Pharmacal Company Recent Developments/Updates

Table 125. OraCoat Company Information

Table 126. OraCoat Description and Business Overview

Table 127. OraCoat Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. OraCoat Drugs for Xerostomia Product

Table 129. OraCoat Recent Developments/Updates

Table 130. Cumberland Pharmaceuticals, Inc. Company Information

Table 131. Cumberland Pharmaceuticals, Inc. Description and Business Overview

Table 132. Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Product

Table 134. Cumberland Pharmaceuticals, Inc. Recent Developments/Updates

Table 135. Fleet, C.B., Company Company Information

Table 136. Fleet, C.B., Company Description and Business Overview

Table 137. Fleet, C.B., Company Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Fleet, C.B., Company Drugs for Xerostomia Product

Table 139. Fleet, C.B., Company Recent Developments/Updates

Table 140. Parnell Pharmaceuticals, Inc Company Information

Table 141. Parnell Pharmaceuticals, Inc Description and Business Overview

Table 142. Parnell Pharmaceuticals, Inc Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Parnell Pharmaceuticals, Inc Drugs for Xerostomia Product

Table 144. Parnell Pharmaceuticals, Inc Recent Developments/Updates

Table 145. Clinigen Company Information

Table 146. Clinigen Description and Business Overview

Table 147. Clinigen Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Clinigen Drugs for Xerostomia Product

Table 149. Clinigen Recent Developments/Updates

Table 150. Sun Pharm Company Information

Table 151. Sun Pharm Description and Business Overview

Table 152. Sun Pharm Drugs for Xerostomia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Sun Pharm Drugs for Xerostomia Product

Table 154. Sun Pharm Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Drugs for Xerostomia Distributors List

Table 158. Drugs for Xerostomia Customers List

Table 159. Drugs for Xerostomia Market Trends

Table 160. Drugs for Xerostomia Market Drivers

Table 161. Drugs for Xerostomia Market Challenges

Table 162. Drugs for Xerostomia Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Drugs for Xerostomia

Figure 2. Global Drugs for Xerostomia Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drugs for Xerostomia Market Share by Type: 2024 & 2031

Figure 4. Spray Product Picture

Figure 5. Oral Liquid Product Picture

Figure 6. Buccal Tablet Product Picture

Figure 7. Mouth Wash Product Picture

Figure 8. Global Drugs for Xerostomia Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Drugs for Xerostomia Market Share by Application: 2024 & 2031

Figure 10. Supermarket

Figure 11. Hospital

Figure 12. Other

Figure 13. Global Drugs for Xerostomia Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Drugs for Xerostomia Market Size (2020-2031) & (US$ Million)

Figure 15. Global Drugs for Xerostomia Sales (2020-2031) & (K Units)

Figure 16. Global Drugs for Xerostomia Average Price (US$/Unit) & (2020-2031)

Figure 17. Drugs for Xerostomia Report Years Considered

Figure 18. Drugs for Xerostomia Sales Share by Manufacturers in 2024

Figure 19. Global Drugs for Xerostomia Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Drugs for Xerostomia Players: Market Share by Revenue in Drugs for Xerostomia in 2024

Figure 21. Drugs for Xerostomia Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Drugs for Xerostomia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Drugs for Xerostomia Sales Market Share by Country (2020-2031)

Figure 24. North America Drugs for Xerostomia Revenue Market Share by Country (2020-2031)

Figure 25. United States Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Drugs for Xerostomia Sales Market Share by Country (2020-2031)

Figure 28. Europe Drugs for Xerostomia Revenue Market Share by Country (2020-2031)

Figure 29. Germany Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Drugs for Xerostomia Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Drugs for Xerostomia Revenue Market Share by Region (2020-2031)

Figure 36. China Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Drugs for Xerostomia Sales Market Share by Country (2020-2031)

Figure 46. Latin America Drugs for Xerostomia Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Drugs for Xerostomia Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Drugs for Xerostomia Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Drugs for Xerostomia Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Drugs for Xerostomia by Type (2020-2031)

Figure 56. Global Revenue Market Share of Drugs for Xerostomia by Type (2020-2031)

Figure 57. Global Drugs for Xerostomia Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Drugs for Xerostomia by Application (2020-2031)

Figure 59. Global Revenue Market Share of Drugs for Xerostomia by Application (2020-2031)

Figure 60. Global Drugs for Xerostomia Price (US$/Unit) by Application (2020-2031)

Figure 61. Drugs for Xerostomia Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Intrathecal Drug Pump Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7E13922

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Radiation Dermatitis Medicines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A12488

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global 0.9% Sodium Chloride Intravenous Infusion Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-1J12515

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Drugs used for Bowel Preparation Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39C12528

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions